SCHEMBL25975016

SCHEMBL25975016

CN1CC(n2ccc(I)cc2=O)C1

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.34
CASP3 P42574 1/20 0.31
SRD5A1 P18405 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL588936 0.82 AOC3 (0.37)
SCHEMBL26031341 0.81 OPRM1 (0.35) OPRM1
SCHEMBL25975003 0.74 BMPR1B (0.30)
SCHEMBL25767985 0.73 DRD2 (0.35) OPRM1
SCHEMBL27389451 0.69 HTR6 (0.36)
SCHEMBL117132 0.69
SCHEMBL25975010 0.68 CNR2 (0.40)
SCHEMBL17083420 0.63 HSD11B1 (0.36) CASP3
SCHEMBL256009 0.62 MAP2K2 (0.41) CASP3
SCHEMBL31434274 0.61 MAPT (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023154282-A1 COMPOUNDS HAVING A T-STRUCTURE FORMED BY AT LEAST FOUR CYCLES FOR USE IN THE TREATMENT OF CANCER AND OTHER INDICATIONS THERAS, INC. (US) 2023-08-17 WO disclosed